Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Histo-blood group A is a risk factor for severe COVID-19.
Garibaldi PMM, Oliveira LC, da Fonseca BA, Auxiliadora-Martins M, Miranda CH, Almado CEL, Langhi DM, Gilio RN, Palma LC, Gomes BBM, Bottura C, Barrientto LC, Donadel CD, Calado RT, De Santis GC. Garibaldi PMM, et al. Among authors: miranda ch. Transfus Med. 2022 Jun;32(3):248-251. doi: 10.1111/tme.12796. Epub 2021 Jun 3. Transfus Med. 2022. PMID: 34085363 Free PMC article.
In vivo demonstration of microvascular thrombosis in severe COVID-19.
do Espírito Santo DA, Lemos ACB, Miranda CH. do Espírito Santo DA, et al. Among authors: miranda ch. J Thromb Thrombolysis. 2020 Nov;50(4):790-794. doi: 10.1007/s11239-020-02245-x. Epub 2020 Aug 13. J Thromb Thrombolysis. 2020. PMID: 32789730 Free PMC article.
SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology.
Veras FP, Pontelli MC, Silva CM, Toller-Kawahisa JE, de Lima M, Nascimento DC, Schneider AH, Caetité D, Tavares LA, Paiva IM, Rosales R, Colón D, Martins R, Castro IA, Almeida GM, Lopes MIF, Benatti MN, Bonjorno LP, Giannini MC, Luppino-Assad R, Almeida SL, Vilar F, Santana R, Bollela VR, Auxiliadora-Martins M, Borges M, Miranda CH, Pazin-Filho A, da Silva LLP, Cunha LD, Zamboni DS, Dal-Pizzol F, Leiria LO, Siyuan L, Batah S, Fabro A, Mauad T, Dolhnikoff M, Duarte-Neto A, Saldiva P, Cunha TM, Alves-Filho JC, Arruda E, Louzada-Junior P, Oliveira RD, Cunha FQ. Veras FP, et al. Among authors: miranda ch. J Exp Med. 2020 Dec 7;217(12):e20201129. doi: 10.1084/jem.20201129. J Exp Med. 2020. PMID: 32926098 Free PMC article.
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial.
Lopes MI, Bonjorno LP, Giannini MC, Amaral NB, Menezes PI, Dib SM, Gigante SL, Benatti MN, Rezek UC, Emrich-Filho LL, Sousa BAA, Almeida SCL, Luppino Assad R, Veras FP, Schneider A, Rodrigues TS, Leiria LOS, Cunha LD, Alves-Filho JC, Cunha TM, Arruda E, Miranda CH, Pazin-Filho A, Auxiliadora-Martins M, Borges MC, Fonseca BAL, Bollela VR, Del-Ben CM, Cunha FQ, Zamboni DS, Santana RC, Vilar FC, Louzada-Junior P, Oliveira RDR. Lopes MI, et al. Among authors: miranda ch. RMD Open. 2021 Feb;7(1):e001455. doi: 10.1136/rmdopen-2020-001455. RMD Open. 2021. PMID: 33542047 Free PMC article. Clinical Trial.
Therapeutic anticoagulation in COVID-19 patients.
Lemos ACB, do Espírito Santo DA, Miranda CH. Lemos ACB, et al. Among authors: miranda ch. Thromb Res. 2021 Jul;203:72-73. doi: 10.1016/j.thromres.2021.04.027. Epub 2021 May 3. Thromb Res. 2021. PMID: 33964522 Free PMC article. No abstract available.
High-Dose Convalescent Plasma for Treatment of Severe COVID-19.
De Santis GC, Oliveira LC, Garibaldi PMM, Almado CEL, Croda J, Arcanjo GGA, Oliveira ÉAF, Tonacio AC, Langhi DM Jr, Bordin JO, Gilio RN, Palma LC, Santos EV, Haddad SK, Prado BPA Jr, Pontelli MC, Gomes R, Miranda CH, Auxiliadora Martins M, Covas DT, Arruda E, Fonseca BAL, Calado RT. De Santis GC, et al. Among authors: miranda ch. Emerg Infect Dis. 2022 Mar;28(3):548-555. doi: 10.3201/eid2803.212299. Epub 2022 Jan 26. Emerg Infect Dis. 2022. PMID: 35081022 Free PMC article. Clinical Trial.
Impact of a dental care intervention on the hospital mortality of critically ill patients admitted to intensive care units: A quasi-experimental study.
Ribeiro ILA, Bellissimo-Rodrigues WT, Mussolin MG, Innocentini LMAR, Marangoni ATD, Macedo LD, Barbosa-Júnior F, de Souza HCC, Menegueti MG, Pereira APS, Gaspar GG, Schmidt A, Miranda CH, Lovato WJ, Puga ML, Auxiliadora-Martins M, Basile-Filho A, Bellissimo-Rodrigues F. Ribeiro ILA, et al. Among authors: miranda ch. Am J Infect Control. 2022 Oct;50(10):1156-1161. doi: 10.1016/j.ajic.2022.01.022. Epub 2022 Jan 30. Am J Infect Control. 2022. PMID: 35108582
Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration.
Tritschler T, Mathieu ME, Skeith L, Rodger M, Middeldorp S, Brighton T, Sandset PM, Kahn SR, Angus DC, Blondon M, Bonten MJ, Cattaneo M, Cushman M, Derde LPG, DeSancho MT, Diehl JL, Goligher E, Jilma B, Jüni P, Lawler PR, Marietta M, Marshall JC, McArthur C, Miranda CH, Mirault T, Morici N, Perepu U, Schörgenhofer C, Sholzberg M, Spyropoulos AC, Webb SA, Zarychanski R, Zuily S, Le Gal G; International Network of VENous Thromboembolism Clinical Research Networks INVENT-VTE. Tritschler T, et al. Among authors: miranda ch. J Thromb Haemost. 2020 Nov;18(11):2958-2967. doi: 10.1111/jth.15094. Epub 2020 Oct 1. J Thromb Haemost. 2020. PMID: 32888372 Free PMC article. Review.
Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients.
Amaral NB, Rodrigues TS, Giannini MC, Lopes MI, Bonjorno LP, Menezes PISO, Dib SM, Gigante SLG, Benatti MN, Rezek UC, Emrich-Filho LL, Sousa BA, Almeida SCL, Luppino-Assad R, Veras FP, Schneider AH, Leiria LOS, Cunha LD, Alves-Filho JC, Cunha TM, Arruda E, Miranda CH, Pazin-Filho A, Auxiliadora-Martins M, Borges MC, Fonseca BAL, Bollela VR, Del-Ben CM, Cunha FQ, Santana RC, Vilar FC, Zamboni DS, Louzada-Junior P, Oliveira RDR. Amaral NB, et al. Among authors: miranda ch. Inflamm Res. 2023 May;72(5):895-899. doi: 10.1007/s00011-023-01718-y. Epub 2023 Mar 14. Inflamm Res. 2023. PMID: 36917217 Free PMC article. Clinical Trial.
47 results